First International Beta Cell Therapy Symposium, focus on Diabetes Management
Register now for the November 14-15 CME event
Cleveland Clinic is pleased to present the first symposium on Beta Cell Therapy for the Management of Diabetes. The symposium is designed to improve the management of patient care and promote collaboration between multidisciplinary providers with enhancement of outcome metrics at the community, national and international level.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
This unique day and a half symposium, led by Cleveland Clinic Transplant Center director, Kareem Abu-Elmagd, MD, will focus on in-depth pathophysiology of diabetes and biology of beta cells. It also features significant advances in the field of basic and clinical science related to treatment of diabetes with beta cell and solid pancreas transplant. It will review prevention, as well newest technologies available for type 1 diabetes including technological advancements from both the biologic and device technology fields, discussing challenges, opportunities and future directions.
By providing relevant discussions of the most current evidence, this educational offering strives to help practitioners acquire knowledge and skills regarding new data and technology which, in turn, can be translated directly to their clinical practice. Our goal is to improve the quality of patient care and enhance the level of information available to the physicians and other providers involved in diagnosis and treatment.
Cleveland Clinic faculty and visiting experts from general surgery, endocrinology, biology, and transplantation will be present to share their expert opinions.
Surgeons, Endocrinologists, Biologists, Nurses, Allied Health Professionals in the specialty area, and other healthcare professionals.
For more information or to register, visit www.ccfcme.org/AttendBetaCell